Toxikon Corporation
Toxikon Corporation is a leading provider of biocompatibility testing services for medical devices and pharmaceuticals. They ensure product safety and regulatory compliance.
Toxikon Corporation specializes in comprehensive biocompatibility testing, offering a full suite of services to meet the rigorous demands of the medical device and pharmaceutical industries. Their expertise ensures that products are safe for human use and comply with global regulatory standards such as ISO 10993. They are dedicated to providing reliable data and expert consultation to support product development and market entry. With a commitment to scientific excellence and client success, Toxikon Corporation partners with manufacturers to navigate the complex landscape of regulatory requirements. Their state-of-the-art facilities and experienced team deliver accurate and timely results, facilitating the approval process for innovative healthcare solutions. They are a trusted resource for biocompatibility assessments, contributing to the safety and efficacy of medical products worldwide.
About
**Who they are**
Toxikon Corporation is a provider of preclinical medical device testing and consulting services. They have over 40 years of experience in the field.
**Expertise & scope**
* Conduct approximately 6,500 studies per year.
* Offer specialized guidance for device development.
* Provide based in vitro alternatives.
**Reputation / proof points**
* 40+ years of experience in preclinical medical device testing and consulting.
* 150 dedicated specialists.
Toxikon Corporation is a provider of preclinical medical device testing and consulting services. They have over 40 years of experience in the field.
**Expertise & scope**
* Conduct approximately 6,500 studies per year.
* Offer specialized guidance for device development.
* Provide based in vitro alternatives.
**Reputation / proof points**
* 40+ years of experience in preclinical medical device testing and consulting.
* 150 dedicated specialists.
Additional information
Toxikon Corporation's medical device testing business was part of Labcorp's Early Development business, which was sold to NAMSA on January 7, 2026. Labcorp committed to completing all ongoing studies and prioritizing clients during this transition. The content provided appears to be from Labcorp's historical pages regarding this business unit, which is now part of NAMSA. Therefore, current services and capabilities should be verified directly with NAMSA.
Key Highlights
-
Over 40 years of experience in preclinical medical device testing and consulting.
Source
“40+ years of experience in preclinical medical device testing and consulting”
-
Employs 150 dedicated specialists.
Source
“Our 150 dedicated specialists conduct ~6,500 studies per year*”
-
Conducts approximately 6,500 studies annually.
Source
“Our 150 dedicated specialists conduct ~6,500 studies per year*”
Certifications & Trust Signals
-
The medical device testing business was formerly part of Labcorp.
Source
“Important Update: Our medical device testing business has joined NAMSA”
Buyer Snapshot
Best for
- Medical device manufacturers seeking preclinical testing.
- Companies needing guidance in device development.
How engagement typically works
- Project-based study execution.
- Consultative guidance for development.
Typical deliverables
- Preclinical test reports.
- Device development consulting.
Good to know
- Best when seeking established experience in medical device testing.
HQ:
USA
Languages:
English
Claim status:
Listed
Services & Capabilities
Biocompatibility Testing (ISO 10993 Program)
Industries:
Medical Devices
Pricing model:
Custom pricing
Iso10993 Standards Supported:
ISO 10993-1, ISO 10993-5, USP <87>, USP <88>
Test Types Offered:
Cytotoxicity, Irritation, Systemic toxicity, Genotoxicity, Implantation, Hemocompatibility, Pyrogenicity
Is Accredited:
Yes
Accreditation Body:
A2LA
Glp Compliant:
Yes
Has In House Toxicology:
Yes
Toxicology Capabilities:
Toxikon offers a comprehensive suite of biocompatibility testing services, including cytotoxicity, sensitization, irritation, systemic toxicity, genotoxicity, implantation, hemocompatibility, pyrogenicity, carcinogenicity, reproductive toxicity, biodegradation, and pharmacokinetics. They also support various ISO 10993 standards and USP <87>/<88>.
Contact Types Supported:
Surface contact, External communicating, Implant
Duration Types Supported:
Limited (< 24h), Prolonged (24h - 30d), Permanent (> 30d)
Rush Available:
Yes
Sample Requirements:
Samples must be submitted with a completed test request form and a certificate of analysis.
Sample Return Policy:
Return
Nda Support:
Yes
Minimum Project Size:
$10-25k
Lead Time Band:
Start in 4-8 weeks
Quote SLA:
3-5 business days
Additional biocompatibility_testing Details
Iso10993 Standards Supported
ISO 10993
Test Types Offered
Biocompatibility testing
Contact Types Supported
Surface contact, External communicating, Implant
Duration Types Supported
Limited (< 24h), Prolonged (24h - 30d), Permanent (> 30d)
Lead Time Band
Start in 4-8 weeks
Quote SLA
3-5 business days
Sample Return Policy
Return
Minimum Project Size
$50k+
Pricing Model
Per project
